OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy

BACKGROUND: Glioblastoma is the most malignant human brain tumor and has a dismal prognosis; however, some patients show long-term survival. The interaction between the costimulatory molecule OX40 and its ligand OX40L generates key signals for T-cell activation. The augmentation of this interaction...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Cancer
Main Authors: Shibahara, Ichiyo, Saito, Ryuta, Zhang, Rong, Chonan, Masashi, Shoji, Takuhiro, Kanamori, Masayuki, Sonoda, Yukihiko, Kumabe, Toshihiro, Kanehira, Masahiko, Kikuchi, Toshiaki, So, Takanori, Watanabe, Takashi, Takahashi, Hiroaki, Iwabuchi, Erina, Tanaka, Yuetsu, Shibahara, Yukiko, Sasano, Hironobu, Ishii, Naoto, Tominaga, Teiji
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4339477/
https://ncbi.nlm.nih.gov/pubmed/25744203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0307-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍